Inventor · disambiguated record
Yang Sun
Also filed as: SUN YANG · SUN YANG-SHENG
5 granted patents·5 pending applications·4 citations·filing 2010–2025
66Inventor score
Files withGUANGZHOU REFORGENE MEDICINE CO LTD4MASSACHUSETTS GEN HOSPITAL2BEIJING SYNSORTECH CO LTD1CHUGAI PHARMACEUTICAL CO LTD1HUDSON BIOPHARMA INC1
Top patents by PatentIndex Score
10 records- 0174US12297450B2CRISPR-Cas13 system and use thereofGUANGZHOU REFORGENE MEDICINE CO LTD·Filed 2024·Granted May 13, 2025·0 cites·27 claims
- 0273US12077577B2Polypeptide comprising aggrecan binding domain and carrying moietyCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Granted Sep 3, 2024·1 cites·27 claims
- 0371US9701685B2Spiropyrrolidines as MDM2 inhibitorsHUDSON BIOPHARMA INC·Filed 2015·Granted Jul 11, 2017·3 cites·20 claims
- 0470US12497603B2Cas effector proteins, gene editing systems, and uses thereofGUANGZHOU REFORGENE MEDICINE CO LTD·Filed 2024·Granted Dec 16, 2025·0 cites·10 claims
- 0569US2025122194A1Novel small molecule inhibitors of tead transcription factorsMASSACHUSETTS GEN HOSPITAL·Filed 2024·Application pending·0 cites
- 0660US2024279630A1Isolated cas13 protein and use thereofGUANGZHOU REFORGENE MEDICINE CO LTD·Filed 2024·Application pending·0 cites
- 0759US2025250590A1Crispr-cas13 system and use thereofGUANGZHOU REFORGENE MEDICINE CO LTD·Filed 2025·Application pending·0 cites
- 0855US12187722B2Small molecule inhibitors of TEAD transcription factorsMASSACHUSETTS GEN HOSPITAL·Filed 2020·Granted Jan 7, 2025·0 cites·23 claims
- 0952US2024002915A1Method for testing target nucleic acid in sampleBEIJING SYNSORTECH CO LTD·Filed 2021·Application pending·0 cites
- 1032US2012238566A1Use of cell autophagy (type ii cell apoptosis) inhibitorsJIANG CHENGYU·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yang Sun files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →